Global Tech Times
SEE OTHER BRANDS

The best science and technology news from the world

Global Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Times.

Press releases published on May 16, 2025

Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.

Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.

VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to its announcement on March 26, 2025, it has received from the TSX Venture Exchange (the “Exchange”) …

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound …

NordVPN launches full GUI for its Linux app

NordVPN launches full GUI for its Linux app

LONDON, May 16, 2025 (GLOBE NEWSWIRE) -- NordVPN, a cybersecurity company, has announced an update for its Linux application – the launch of a full graphical user interface (GUI). This marks a new era for Linux users, making it easier to connect securely …

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

Company intends to provide an interim read out by the end of summer 2025 Top-line results anticipated in Q4 2025; study on track to support U.S. pivotal trial initiation in 2026 BERKELEY, Calif. and MAINZ, Germany, May 16, 2025 (GLOBE NEWSWIRE) -- Mainz …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst …

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day

WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May …

Spectral Medical to Present at the 3rd Annual  H.C. Wainwright BioConnect Investor Conference

Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a …

PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a specialty pharmaceutical company focused on ketamine for unmet medical needs, today announced the U.S. Food and Drug …

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., May 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …

NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project

NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on its ongoing 25,000 metre diamond drill program initially announced on January 22, 2025 at the Company’ …

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Company Urges Stockholders to Vote ‘FOR’ Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Proposal #2 SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE …

MicroAlgo Inc. Announces a Quantum Entanglement-Based Novel Training Algorithm — Entanglement-Assisted Training Algorithm for Supervised Quantum Classifiers

MicroAlgo Inc. Announces a Quantum Entanglement-Based Novel Training Algorithm — Entanglement-Assisted Training Algorithm for Supervised Quantum Classifiers

shenzhen, May 16, 2025 (GLOBE NEWSWIRE) -- Shenzhen, May. 16, 2025––MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the development of a novel quantum entanglement-based training algorithm — the Entanglement-Assisted Training …

JOYY to Announce First Quarter 2025 Financial Results on May 26, 2025

JOYY to Announce First Quarter 2025 Financial Results on May 26, 2025

SINGAPORE, May 16, 2025 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced that it plans to release its first quarter 2025 financial results after the U.S. market closes on May 26, 2025. The …

Richtech Robotics Expands ADAM Robot Capabilities with AI Powered Artisanal Espresso System

Richtech Robotics Expands ADAM Robot Capabilities with AI Powered Artisanal Espresso System

New system utilizes advancements in physical AI to provide customers efficient and precise artisanal coffee products Las Vegas, NV, May 16, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a Nevada-based …

NowVertical Group Announces First Quarter 2025 Earnings Release Date and Financial Update Webinar

NowVertical Group Announces First Quarter 2025 Earnings Release Date and Financial Update Webinar

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) ("NowVertical" or the "Company"), a leading data and AI solutions provider, will announce its 2025 first quarter results after the market close on Wednesday, May 21, 2025. This …

Global Technologies, Ltd. Files Third Quarter 10-Q with SEC Highlighting Substantial Revenue Growth and Strategic Expansion

Global Technologies, Ltd. Files Third Quarter 10-Q with SEC Highlighting Substantial Revenue Growth and Strategic Expansion

GREENSBORO, NC, May 16, 2025 (GLOBE NEWSWIRE) -- Global Technologies, Ltd. (OTC PINK: GTLL) (“Global” or the “Company”), a publicly traded, multi-operational company driving innovation and sustainable growth across the technology and service sectors, today …

Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference

Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference

First conference presentations for: Phase 2b study for nontuberculous mycobacterial pulmonary disease (NTM PD) caused by Mycobacterium abscessus complex (MABc) Phase 3 OPTIC-2 study in moderate-to-severe community-acquired bacterial pneumonia (CABP) BOSTON …

OptimizeRx to Participate in Upcoming Investor Conferences

OptimizeRx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today …

AgEagle Aerial Systems Reports First Quarter Fiscal Year 2025 Financial Results

AgEagle Aerial Systems Reports First Quarter Fiscal Year 2025 Financial Results

Improved financial performance highlighted by strong gross margin improvement and significant reduction in operating expenses  WICHITA, Kan., May 16, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of best-in-class …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service